These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 33100632)
1. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial and the appropriateness of revascularization. Narayan P Indian J Thorac Cardiovasc Surg; 2020 Nov; 36(6):664-667. PubMed ID: 33100632 [TBL] [Abstract][Full Text] [Related]
2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671 [TBL] [Abstract][Full Text] [Related]
3. Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial? Gala ABE; Curzen N Heart Int; 2020; 14(1):13-15. PubMed ID: 36277662 [TBL] [Abstract][Full Text] [Related]
4. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS; Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098 [TBL] [Abstract][Full Text] [Related]
6. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496 [TBL] [Abstract][Full Text] [Related]
7. Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Spertus JA; Maron DJ; Cohen DJ; Kolm P; Hartigan P; Weintraub WS; Berman DS; Teo KK; Shaw LJ; Sedlis SP; Knudtson M; Aslan M; Dada M; Boden WE; Mancini GB; Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):409-18. PubMed ID: 23838107 [TBL] [Abstract][Full Text] [Related]
8. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials. Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270 [TBL] [Abstract][Full Text] [Related]
9. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393 [TBL] [Abstract][Full Text] [Related]
10. Who is eligible for randomized trials? A comparison between the exclusion criteria defined by the ISCHEMIA trial and 3102 real-world patients with stable coronary artery disease undergoing stent implantation in a single cardiology center. Wasilewski J; Poloński L; Lekston A; Osadnik T; Reguła R; Bujak K; Kurek A Trials; 2015 Sep; 16():411. PubMed ID: 26373291 [TBL] [Abstract][Full Text] [Related]
11. ISCHEMIA trial: How to apply the results to clinical practice. Vidal-Perez R; Bouzas-Mosquera A; Peteiro J; Vazquez-Rodriguez JM World J Cardiol; 2021 Aug; 13(8):237-242. PubMed ID: 34589162 [TBL] [Abstract][Full Text] [Related]
12. Coronary revascularisation in patients with ischaemic cardiomyopathy. Ryan M; Morgan H; Petrie MC; Perera D Heart; 2021 Apr; 107(8):612-618. PubMed ID: 33436491 [TBL] [Abstract][Full Text] [Related]
13. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial. Guo MH; Nantsios A; Ruel M Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193 [TBL] [Abstract][Full Text] [Related]
14. Coronary artery stents: a rapid systematic review and economic evaluation. Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315 [TBL] [Abstract][Full Text] [Related]
15. Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation. Duarte A; Llewellyn A; Walker R; Schmitt L; Wright K; Walker S; Rothery C; Simmonds M Health Technol Assess; 2021 Sep; 25(56):1-230. PubMed ID: 34588097 [TBL] [Abstract][Full Text] [Related]
16. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease. Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382 [TBL] [Abstract][Full Text] [Related]
17. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease. Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597 [TBL] [Abstract][Full Text] [Related]
18. What Is the Clinical Impact of Stress CMR After the ISCHEMIA Trial? Pezel T; Silva LM; Bau AA; Teixiera A; Jerosch-Herold M; Coelho-Filho OR Front Cardiovasc Med; 2021; 8():683434. PubMed ID: 34164444 [TBL] [Abstract][Full Text] [Related]